Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on September 14, 2026

2 hours ago

Ascendis Announces Planned $400 Million Share Repurchase Program

Indeterminate GlobeNewswire

2 hours ago

Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

Indeterminate GlobeNewswire

2 hours ago

What a Pharmacy Software Conversion Involves, From Data Migration to 90 Days of Support

Indeterminate GlobeNewswire

2 hours ago

Mike Tomlin to Keynote NC Central Basketball Tip-Off Banquet in First Fall Away From the Sideline

Indeterminate GlobeNewswire

2 hours ago

Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs

Indeterminate GlobeNewswire

3 hours ago

NowSecure Finds 1 in 4 Mobile Apps May Expose Functionality to AI Agents Ahead of iOS 27

Indeterminate GlobeNewswire

3 hours ago

Filmore Brings Construction Equipment Demand Into Microsoft Teams

Indeterminate GlobeNewswire

3 hours ago

Veea Inc. and NovaGen announce potential merger to launch an Edge AI-Powered Global Health Platform

Indeterminate GlobeNewswire

3 hours ago

Robin van Poelje to Retire as CEO of Topicus.com Inc. on October 1, 2026; Board Names Ramon Zanders as his Successor

Indeterminate GlobeNewswire

3 hours ago

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire

3 hours ago

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

4 hours ago

NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications

Indeterminate GlobeNewswire

4 hours ago

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Indeterminate GlobeNewswire

4 hours ago

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

Indeterminate GlobeNewswire

4 hours ago

BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid

Indeterminate GlobeNewswire

4 hours ago

Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update

Indeterminate GlobeNewswire

4 hours ago

ETC Awarded $11.7 Million in Contracts

Indeterminate GlobeNewswire

4 hours ago

VdoCipher Report Highlights How Piracy and Unauthorized Sharing Are Costing Course Creators Revenue

Indeterminate GlobeNewswire

5 hours ago

QCI Expands Metrics with Next-Day Slot Performance Data

Indeterminate GlobeNewswire

5 hours ago

US-Kriegsministerium sagt wegweisende Investition von 450 Millionen US-Dollar in The Elmet Group zu, um Wolfram-Lieferkette der USA zu sichern

Indeterminate GlobeNewswire